Scott Juda insider trades

Open-market stock purchases and sales by Scott Juda, Director at Inmune Bio, Inc, from SEC Form 4 filings since Jun 3, 2019.

Recent trades

DateStockTradeValue
Dec 1, 2025INMB Inmune Bio, IncBought (not open market)—
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$333K
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$52.5K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$164K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$422K
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$162K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$396K
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$24K
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$28.5K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$341K
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$48.8K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$124K
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$18.8K

Companies traded

  • INMB Inmune Bio, Inc: 7 buys, last Dec 1, 2025

Get free alerts when Scott Juda files a new trade →